DE SIMONE, GIOVANNI
 Distribuzione geografica
Continente #
AS - Asia 12.529
NA - Nord America 11.284
EU - Europa 10.596
SA - Sud America 1.828
AF - Africa 299
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 14
Totale 36.579
Nazione #
US - Stati Uniti d'America 10.754
SG - Singapore 7.509
RU - Federazione Russa 5.069
CN - Cina 2.184
BR - Brasile 1.476
HK - Hong Kong 1.291
IT - Italia 956
VN - Vietnam 859
UA - Ucraina 807
DE - Germania 776
SE - Svezia 724
FI - Finlandia 677
IE - Irlanda 481
NL - Olanda 416
CA - Canada 351
GB - Regno Unito 297
IN - India 152
AR - Argentina 134
ZA - Sudafrica 104
MX - Messico 103
FR - Francia 87
AT - Austria 68
EC - Ecuador 67
BD - Bangladesh 63
ID - Indonesia 63
PL - Polonia 61
CI - Costa d'Avorio 60
TR - Turchia 55
JP - Giappone 49
IQ - Iraq 40
VE - Venezuela 33
CO - Colombia 32
ES - Italia 27
KR - Corea 27
UZ - Uzbekistan 25
MA - Marocco 24
CL - Cile 23
PY - Paraguay 22
BE - Belgio 20
LT - Lituania 20
PK - Pakistan 20
KE - Kenya 17
SA - Arabia Saudita 17
IR - Iran 16
DO - Repubblica Dominicana 15
EG - Egitto 15
IL - Israele 15
PE - Perù 14
AE - Emirati Arabi Uniti 13
RO - Romania 13
UY - Uruguay 13
AU - Australia 12
BG - Bulgaria 12
BO - Bolivia 12
CH - Svizzera 11
JO - Giordania 11
AZ - Azerbaigian 10
CZ - Repubblica Ceca 10
TN - Tunisia 10
KH - Cambogia 9
NP - Nepal 9
JM - Giamaica 7
KZ - Kazakistan 7
MY - Malesia 7
TJ - Tagikistan 7
CR - Costa Rica 6
EU - Europa 6
GE - Georgia 6
HR - Croazia 6
KG - Kirghizistan 6
NZ - Nuova Zelanda 6
PS - Palestinian Territory 6
TT - Trinidad e Tobago 6
TW - Taiwan 6
AD - Andorra 5
BA - Bosnia-Erzegovina 5
BH - Bahrain 5
DK - Danimarca 5
ET - Etiopia 5
HN - Honduras 5
LA - Repubblica Popolare Democratica del Laos 5
ME - Montenegro 5
MR - Mauritania 5
NC - Nuova Caledonia 5
PA - Panama 5
PH - Filippine 5
RS - Serbia 5
AO - Angola 4
BB - Barbados 4
CW - ???statistics.table.value.countryCode.CW??? 4
DZ - Algeria 4
GA - Gabon 4
GT - Guatemala 4
KW - Kuwait 4
MD - Moldavia 4
ML - Mali 4
NG - Nigeria 4
NI - Nicaragua 4
PR - Porto Rico 4
PT - Portogallo 4
Totale 36.459
Città #
Singapore 3.247
Chandler 1.361
Hong Kong 1.288
Moscow 1.201
Jacksonville 891
Millbury 626
Beijing 622
Ashburn 611
Santa Clara 532
Princeton 519
Amsterdam 390
Nanjing 358
Los Angeles 332
Boston 302
Ottawa 277
Ho Chi Minh City 259
Buffalo 242
Wilmington 235
Munich 222
Naples 221
Dallas 157
Hefei 149
Napoli 149
Woodbridge 149
Ann Arbor 148
Hanoi 141
Redondo Beach 137
Dong Ket 134
Houston 129
Nanchang 129
The Dalles 128
São Paulo 125
Seattle 114
New York 105
Boardman 104
Kronberg 93
Des Moines 88
Helsinki 88
Hebei 85
Turku 82
Shenyang 75
Mexico City 63
Jiaxing 60
San Jose 60
Norwalk 59
Falls Church 54
Pune 54
Tianjin 52
Warsaw 52
Changsha 51
Nuremberg 49
Rio de Janeiro 47
Tokyo 47
Falkenstein 45
Brooklyn 44
Haiphong 44
Rome 43
Chicago 41
Dublin 37
Frankfurt am Main 36
Atlanta 35
Johannesburg 34
Belo Horizonte 33
London 33
Orem 33
Stockholm 33
Vienna 33
Chennai 31
Da Nang 31
Hangzhou 30
Lawrence 30
Brasília 28
Kunming 28
Montreal 27
Curitiba 26
Denver 26
San Francisco 26
Washington 26
Orange 24
Phoenix 24
Redwood City 24
Toronto 24
Guayaquil 23
Manchester 23
Milan 23
Guarulhos 22
Hải Dương 22
Poplar 21
Tashkent 21
Ankara 20
Guangzhou 19
Seoul 18
Campinas 17
Shanghai 17
Ninh Bình 16
São Bernardo do Campo 16
Biên Hòa 15
Dearborn 15
Quito 15
Dhaka 14
Totale 18.159
Nome #
A case of phenotypic Anderson-Fabry disease in a female patient 158
[Hemodynamic adaptation in severe obesity with or without arterial hypertension] 155
Type of myocardial infarction presentation in patients with chronic kidney disease. 154
Body Build and Risk of Cardiovascular Events in Hypertension and Left Ventricular Hypertrophy. The LIFE Study. 151
2D and 3D strain for detection of subclinical anthracycline cardiotoxicity in breast cancer patients: a balance with feasibility 144
Is High Pulse Pressure a Marker of Preclinical Cardiovascular Disease? 139
Higher pulse pressure and risk for cardiovascular events in patients with essential hypertension: The Campania Salute Network 134
2018 ESC/ESH Guidelines for the management of arterial hypertension 131
Different Normalizations for Body Size and Population Attributable Risk of Left Ventricular Hypertrophy: the MAVI Study. 128
Utility of Thiazide Diuretics in Combination Therapy of Hypertension 125
Atrial Dilatation Development in Hypertensive Treated Patients: The Campania-Salute Network 125
Weight loss facilitates reduction of left ventricular mass in obese hypertensive patients: The Campania Salute Network 124
Estimate of White-coat Effect and Arterial Stiffness 120
Effects of Sibutramine-induced Weight Loss on Cardiovascular System in Obese Subjects 119
Association of suboptimal blood pressure control with body size and metabolic abnormalities. 119
Improved cardiovascular diagnostic accuracy by pocket size imaging device in non cardiologic outpatients. The NaUSiCa (Naples Ultrasound Sthetoscope in Cardiology) Study. 119
Effects of Nutraceuticals on Prevalence of Metabolic Syndrome and on Calculated Framingham Risk Score in Subjects with Dyslipidemia 119
Left Ventricular Diastolic Dysfunction in Type I Gaucher Disease: An Echo Doppler Study. 118
Prognostic impact of increased pulse pressure/stroke index in a registry of hypertensive patients: the Campania Salute Network 118
Achievement of target SBP without attention to decrease in DBP can increase cardiovascular morbidity in treated arterial hypertension: the Campania Salute Network registry 118
Depressed myocardial energetic efficiency is associated with increased cardiovascular risk in hypertensive left ventricular hypertrophy 118
Coronary Flow Reserve in Patients with Hypercholesterolemia and without Coronary Heart Disease. 116
Statins and Incident Diabetes 116
Should Thiazide Diuretics be Given as First Line Antihypertensive Therapy or in Addition to Other Medications? 116
Effect of diabetes and metabolic syndrome on myocardial mechano-energetic efficiency in hypertensive patients. The Campania Salute Network 115
Left Venticular Hypertrophy and Carotid Atherosclerosis as Predictors of New-Onset Diabetes 114
CHA2DS2-VASc score and left atrial volume dilatation synergistically predict incident atrial fibrillation in hypertension: an observational study from the Campania Salute Network registry 114
Excessive increase in left ventricular mass identifies hypertensive subjects with clustered geometric and functional abnormalities 113
Left Ventricular Mass Is a Predictor of Follow-Up Uncontrolled Blood Pressure in Hipertensive Patients. 113
Nonsymmetric myocardial contribution to supranormal right ventricular function in the athlete's heart: combined assessment by speckle tracking and real time three-dimensional echocardiography. 113
Development of New Atherosclerotic Plaque in Hypertensive Patients: The Campania-Salute Network 113
[Nicardipine in the treatment of arterial hypertension: echocardiographic evaluation] 113
Development of Left Ventricular Hypertrophy in Treated Hypertensive Outpatients 113
Target Organ Damage and Target Systolic Blood Pressure in Clinical Practice: The Campania Salute Network 113
Determinants of aortic root dilatation over time in patients with essential hypertension: The Campania Salute Network 113
Carotid plaque offsets sex-related differences in cardiovascular risk of young hypertensive patients 112
Evaluation of concentric Left Ventricular Geometry in Humans: Evidence for Age-Related Systematic Underestimation 112
OBESITY, HEART FAILURE AND SUDDEN DEATH 112
Pressione arteriosa sistolica, diastolica e differenziale: aspetti fisiopatologici. 112
Identification of Phenotype at Risk of Resistant Hypertension 112
Validation of Left Atrial Volume Estimation by Left Atrial Diameter from the Parasternal Long-Axis 111
Normalization of ascending aorta dimension for body size influences pathophysiologic correlation in hypertensive patients: the Campania Salute Network 110
Doppler echocardiography for the assessment of left ventricular diastolic function: methodology, clinical and prognostic value 110
Prevention and treatment of implanted central venous catheter (CVC) - related sepsis: a report after six years of home parenteral nutrition (HPN). 110
Increased Left ventricular Mass and Control of Arterial Hypertension in Hypertensive Patients 110
Cardiovascular ultrasound exploration contributes to predict incident atrial fibrillation in arterial hypertension: the Campania Salute Network 110
Effect of Cigarette Smoking on Risk Profile of Patients with Optimally Controlled Hypertension. High Blood Press 2011 109
Association of Blood Pressure With Blood Viscosity in American Indians. The Strong Heart Study 108
Prevalence and characteristics of true and apparent treatment resistant hypertension in the Campania Salute Network. 108
Determinants of decline of renal function in treated hypertensive patients: the Campania Salute Network 108
Management of the patient with left ventricular hypertrophy 107
High-dose recombinant interleukin-2/verapamil combination in advanced cancer. 107
2D Speckle Strain Immaging Identifies Depressed Left Atrial function in Hypertensive Patients with Diastolic Dysfunction 107
Initial Left Ventricular Mass Predicts Probability of Uncontrolled Blood Pressure in Arterial Hypertension 106
Clinical Predictors of Development of New Lv Hypertrophy in Treated Hypertensive Patients 106
A challenging diagnosis of dyspnea: A case report of contralateral reexpansion pulmonary edema 106
Does Therapy With Statins Increase Risk Of Diabetes? 104
Carotid Atherosclerosis Predicts Blood Pressure Control in Patients With Hypertension: The Campania Salute Network Registry 104
Normalization for body size and population-attributable risk of left ventricular hypertrophy: the Strong Heart Study. 103
Acute hyperglycemia does not affect the reactivity of coronary microcirculation in humans. 103
Atrial Strain by 2d Speckle Tracking Outperforms Atrial Volume in Identifying Hypertensive Patients with Diastolic Dysfunction 103
Classes of Antihypertensive Medications and Blood Pressure Control in Relation to Metabolic Risk Factors 103
Partial deficiency of adrenal 11-hydroxylase: A possible cause of primary hypertension 103
Left Ventricular Hypertrophy Regression in Hypertensives: a New Hard Challenge 103
Site-dependency of the E/e' ratio in predicting invasive left ventricular filling pressure in patients with suspected or ascertained coronary artery disease. 103
Interstitial syndrome-lung ultrasound B lines: A potential marker for pulmonary metastases? A case series 103
Effects of Dipeptidyl Peptidase-4 Inhibitor Linagliptin on Left Ventricular Dysfunction in Patients with Type 2 Diabetes and Concentric Left Ventricular Geometry (the DYDA 2™ Trial). Rationale, Design, and Baseline Characteristics of the Study Population 103
Preclinical Systolic Dysfunction in Patients with Stage 3 Chronic Renal Disease. 102
Prevalence and Prognostic Significance of Wall-Motion Abnormalities in Adults without Clinically Recognized Cardiovascilar Disease 101
Link of Nonhemodynamic factors to hemodynamic determinants of left ventricular hypertrophy 101
Metabolic risk factors and left ventricular hypertrophy. 101
Regressione del danno d’organo cardiaco con Telmisartan nello studio ONTARGET/TRASCEND. 100
Arterial stiffness is associated with carotid atherosclerosis in hypertensive patients (the campania salute network). 100
Supernormal contractility in primary hypertension without left ventricular hypertrophy 99
Influence of fat-free mass on detection of appropriateness of left ventricular mass: the HyperGEN Study. 99
Appropriate or inappropriate left ventricular mass in the presence or absence of prognostically adverse left ventricular hypertrophy. 99
Does information on systolic and diastolic function improve prediction of a cardiovascular event by left ventricular hypertrophy in arterial hypertension? 99
Effects of nutraceuticals on prevalence of metabolic syndrome and on calculated framingham risk score in individuals with dyslipidemia. 99
Statins therapy in atrial fibrillation in hypertensive patients. 99
Correlates of global area strain in native hypertensive patients: a three-dimensional speckle-tracking echocardiography study. 99
Statins Therapy and Incidence of Atrial Fibrillation in Hypertensive Patients 99
Serial echocardiographic assessment of left ventricular mass: how blinded should readers be? 98
Impact of obesity on cardiac geometry and function in a population of adolescents: the Strong Heart Study. 98
CORONARY FLOW RESERVE IN HYPERTENSIVE PATIENTS WITH APPROPRIATE OR INAPPROPRIATE LEFT VENTRICULAR MASS. 98
Atrial Strain by 2D Speckle Tracking Outperforms Atrial Volume in Identifying Hypertensive Patients with Diastolic Dysfunction 98
Predictors of Lack of Regression of Left Ventricular Hypertrophy in Treated Hypertensive Patients. 98
Identification of Phenotype at Risk of Transition from Systo-Diastolic Hypertension to Isolated Systolic Hypertension 98
Renal artery stenosis in a young female patient with severe hypertension - a case report 98
Association of Myocardial Energetic Efficiency with Circumferential and Longitudinal Left Ventricular Myocardial Function in Subjects with Increased Body Mass Index (the FATCOR Study) 98
Association of inappropriate left ventricular mass with systolic and diastolic disfunction � The HyperGEN Study 97
Risk factors for arterial hypertension in adults with initial optimal bloodpressure: the Strong Heart Study. 97
Myocardial texture in hypertrophic cardiomyopathy 97
Body composition and fat distribution influence systemic hemodynamics in the absence of obesity: the HyperGEN Study. 96
Haemodynamic Patterns Hypertension by Interaction between Peripheral Resistance and Arterial Stiffness. 96
Left Ventricular Mass in Hypertrophic Cardiomyopathy Assessed by 2D-Echocardiography: Validation with Magnetic Resonance Imaging 96
Antiremodeling Effect of Aldosterone Receptors Blockade with Canrenone in Mild Chronic Heart Failure: Rationale and Design. 95
Prognostic Value of Serial Electrocardiographic Voltage and Repolarization Changes in Essential Hypertension: The HEART Survey Study. 95
Increased left ventricular mass in pre-liver transplantation cirrhotic patients. 95
Identification of Phenotype at Risk of Resistant Hypertension 95
Statins Therapy for Primary Prevention and Risk of Incident Diabetes in Hypertensive Patients 95
Totale 10.994
Categoria #
all - tutte 130.037
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 130.037


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021934 0 0 0 0 0 0 154 13 253 127 214 173
2021/20222.578 75 20 12 20 10 53 40 108 490 114 373 1.263
2022/20233.158 591 200 59 316 381 357 8 295 458 340 128 25
2023/20241.956 72 298 243 73 106 213 31 245 17 53 423 182
2024/202511.833 723 997 50 152 155 497 1.061 769 1.320 1.213 3.771 1.125
2025/202611.350 2.308 1.326 1.834 1.419 3.407 984 72 0 0 0 0 0
Totale 37.113